Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Journal of cancer research and clinical oncology - 1 Oct 2012

Liao Shao-Guang, Liu Lu, Wang Ying, Zhang Ying-Yi, Wang Ya-Jie

Abstract excerpt

PURPOSE: The association between Asp312Asn and Lys751Gln polymorphisms of Xeroderma pigmentosum Group D (XPD) and prostate cancer risk are still inconclusive. For better understanding of the effects of these two polymorphisms on prostate cancer risk, a meta-analysis was performed. METHODS: An extensive search was performed to identify all case-control studies investigating such association. The strength of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Association Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 22644997
DOI: 10.1007/s00432-012-1246-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.PMID 22644997Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.Semantic proximity Read ↗

Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.Semantic proximity Read ↗

Common variants of xeroderma pigmentosum genes and prostate cancer risk.Semantic proximity Read ↗

XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.Semantic proximity Read ↗

Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.Semantic proximity Read ↗

XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.